Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Leiomyosarcoma × Epirubicin × Clear all

Phase

Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Carcinoma, Hepatocellular 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Lymphoma, Large B-Cell, Diffuse 1 Leiomyosarcoma 1 Esophageal Neoplasms 1 Disease Progression 1 Breast Diseases 1 Amenorrhea 1

Interventions

regorafenib 1 pegfilgrastim 1 X-Rays 1 Temozolomide 1 Standard of Care 1 Radiotherapy, Conformal 1 Ifosfamide 1 Fluorodeoxyglucose F18 1 Epirubicin 1 Doxorubicin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05204524 2022-01-24

Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

ChineseAMS

Phase NA Unknown

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡